{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T06:15:54Z","timestamp":1787984154286,"version":"build-2784847793"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271951"],"award-info":[{"award-number":["82271951"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U24A20755"],"award-info":[{"award-number":["U24A20755"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Beijing Natural Science Foundation","award":["L248017"],"award-info":[{"award-number":["L248017"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Radiol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s11604-026-02008-3","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T13:36:15Z","timestamp":1780580175000},"page":"1671-1684","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Intravoxel incoherent motion diffusion-weighted imaging for early response stratification of neoadjuvant immune checkpoint inhibitor plus tyrosine kinase inhibitor in renal cell carcinoma: an exploratory study"],"prefix":"10.1007","volume":"44","author":[{"given":"Huanhuan","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoupeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizhi","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuewei","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaopeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaohui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiyang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingbo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangyou","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5197-871X","authenticated-orcid":false,"given":"Haiyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"issue":"10451","key":"2008_CR1","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/S0140-6736(24)00917-6","volume":"404","author":"M Young","year":"2024","unstructured":"Young M, Jackson-Spence F, Beltran L, Day E, Suarez C, Bex A, et al. Renal cell carcinoma. Lancet. 2024;404(10451):476\u201391. https:\/\/doi.org\/10.1016\/S0140-6736(24)00917-6.","journal-title":"Lancet"},{"issue":"12","key":"2008_CR2","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1001\/jama.2024.12848","volume":"332","author":"TL Rose","year":"2024","unstructured":"Rose TL, Kim WY. Renal cell carcinoma: a review. JAMA. 2024;332(12):1001\u201310. https:\/\/doi.org\/10.1001\/jama.2024.12848.","journal-title":"JAMA"},{"issue":"3","key":"2008_CR3","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.eururo.2018.03.036","volume":"74","author":"CJD Wallis","year":"2018","unstructured":"Wallis CJD, Klaassen Z, Bhindi B, Ye XY, Chandrasekar T, Farrell AM, et al. First-line systemic therapy for metastatic renal cell carcinoma: a systematic review and network meta-analysis. Eur Urol. 2018;74(3):309\u201321. https:\/\/doi.org\/10.1016\/j.eururo.2018.03.036.","journal-title":"Eur Urol"},{"issue":"2","key":"2008_CR4","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3322\/caac.21388","volume":"67","author":"MB Amin","year":"2017","unstructured":"Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, et al. The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more personalized approach to cancer staging. CA Cancer J Clin. 2017;67(2):93\u20139. https:\/\/doi.org\/10.3322\/caac.21388.","journal-title":"CA Cancer J Clin"},{"key":"2008_CR5","unstructured":"National Comprehensive Cancer Network. NCCN guidelines for patients: kidney cancer. 1st ed. 2026."},{"issue":"8","key":"2008_CR6","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.annonc.2024.05.537","volume":"35","author":"T Powles","year":"2024","unstructured":"Powles T, Albiges L, Bex A, Comperat E, Gr\u00fcnwald V, Kanesvaran R, et al. Renal cell carcinoma: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol. 2024;35(8):692\u2013706. https:\/\/doi.org\/10.1016\/j.annonc.2024.05.537.","journal-title":"Ann Oncol"},{"issue":"6","key":"2008_CR7","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.eururo.2025.02.020","volume":"87","author":"A Bex","year":"2025","unstructured":"Bex A, Ghanem YA, Albiges L, Bonn S, Campi R, Capitanio U, et al. European association of urology guidelines on renal cell carcinoma: the 2025 update. Eur Urol. 2025;87(6):683\u201396. https:\/\/doi.org\/10.1016\/j.eururo.2025.02.020.","journal-title":"Eur Urol"},{"issue":"12","key":"2008_CR8","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1016\/S1470-2045(20)30436-8","volume":"21","author":"T Powles","year":"2020","unstructured":"Powles T, Plimack ER, Souli\u00e8res D, Waddell T, Stus V, Gafanov R, et al. Pembrolizumab plus axitinib versus sunitinib monotherapy as first-line treatment of advanced renal cell carcinoma (KEYNOTE-426): extended follow-up from a randomised, open-label, phase 3 trial. Lancet Oncol. 2020;21(12):1563\u201373. https:\/\/doi.org\/10.1016\/S1470-2045(20)30436-8.","journal-title":"Lancet Oncol"},{"issue":"1","key":"2008_CR9","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/s41392-024-01990-2","volume":"9","author":"L Gu","year":"2024","unstructured":"Gu L, Peng C, Liang Q, Huang Q, Lv D, Zhao H, et al. Neoadjuvant toripalimab plus axitinib for clear cell renal cell carcinoma with inferior vena cava tumor thrombus: NEOTAX, a phase 2 study. Signal Transduct Target Ther. 2024;9(1):264. https:\/\/doi.org\/10.1038\/s41392-024-01990-2.","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"2008_CR10","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s10147-024-02471-w","volume":"29","author":"H Ishihara","year":"2024","unstructured":"Ishihara H, Omae K, Nemoto Y, Ishiyama R, Tachibana H, Nishimura K, et al. First-line dual immune checkpoint inhibitor therapies versus combination therapies comprising immune checkpoint inhibitors and tyrosine kinase inhibitors for advanced renal cell carcinoma: a comparative analysis of the effectiveness using real-world data. Int J Clin Oncol. 2024;29(4):473\u201380. https:\/\/doi.org\/10.1007\/s10147-024-02471-w.","journal-title":"Int J Clin Oncol"},{"issue":"4","key":"2008_CR11","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.annonc.2024.12.003","volume":"36","author":"RJ Motzer","year":"2025","unstructured":"Motzer RJ, Porta C, Eto M, Hutson TE, Rha SY, Merchan JR, et al. Biomarker analyses from the phase III randomized CLEAR trial: lenvatinib plus pembrolizumab versus sunitinib in advanced renal cell carcinoma. Ann Oncol. 2025;36(4):375\u201386. https:\/\/doi.org\/10.1016\/j.annonc.2024.12.003.","journal-title":"Ann Oncol"},{"key":"2008_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12154987","author":"SD Martin","year":"2023","unstructured":"Martin SD, Bhuiyan I, Soleimani M, Wang G. Biomarkers for immune checkpoint inhibitors in renal cell carcinoma. J Clin Med. 2023. https:\/\/doi.org\/10.3390\/jcm12154987.","journal-title":"J Clin Med"},{"issue":"6","key":"2008_CR13","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/s41571-024-00891-1","volume":"21","author":"E Hoffmann","year":"2024","unstructured":"Hoffmann E, Masthoff M, Kunz WG, Seidensticker M, Bobe S, Gerwing M, et al. Multiparametric MRI for characterization of the tumour microenvironment. Nat Rev Clin Oncol. 2024;21(6):428\u201348. https:\/\/doi.org\/10.1038\/s41571-024-00891-1.","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"2008_CR14","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1148\/radiology.168.2.3393682","volume":"168","author":"D Le Bihan","year":"1988","unstructured":"Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, Laval-Jeantet M. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology. 1988;168(2):497\u2013505. https:\/\/doi.org\/10.1148\/radiology.168.2.3393682.","journal-title":"Radiology"},{"issue":"2","key":"2008_CR15","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1002\/jmri.28718","volume":"58","author":"I Laothamatas","year":"2023","unstructured":"Laothamatas I, Al Mubarak H, Reddy A, Wax R, Badani K, Taouli B, et al. Multiparametric MRI of solid renal masses: principles and applications of advanced quantitative and functional methods for tumor diagnosis and characterization. J Magn Reson Imaging. 2023;58(2):342\u201359. https:\/\/doi.org\/10.1002\/jmri.28718.","journal-title":"J Magn Reson Imaging"},{"issue":"6","key":"2008_CR16","doi-asserted-by":"publisher","first-page":"853","DOI":"10.3348\/kjr.2016.17.6.853","volume":"17","author":"Y Ding","year":"2016","unstructured":"Ding Y, Zeng M, Rao S, Chen C, Fu C, Zhou J. Comparison of biexponential and monoexponential model of diffusion-weighted imaging for distinguishing between common renal cell carcinoma and fat poor angiomyolipoma. Korean J Radiol. 2016;17(6):853\u201363. https:\/\/doi.org\/10.3348\/kjr.2016.17.6.853.","journal-title":"Korean J Radiol"},{"issue":"1","key":"2008_CR17","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s40644-024-00816-2","volume":"24","author":"J Zhao","year":"2024","unstructured":"Zhao J, Xu H, Fu Y, Ding X, Wang M, Peng C, et al. Development and validation of intravoxel incoherent motion diffusion weighted imaging-based model for preoperative distinguishing nuclear grade and survival of clear cell renal cell carcinoma complicated with venous tumor thrombus. Cancer Imaging. 2024;24(1):164. https:\/\/doi.org\/10.1186\/s40644-024-00816-2.","journal-title":"Cancer Imaging"},{"issue":"1133","key":"2008_CR18","doi-asserted-by":"publisher","first-page":"20210485","DOI":"10.1259\/bjr.20210485","volume":"95","author":"Q Zhu","year":"2022","unstructured":"Zhu Q, Zhu W, Wu J, Chen W, Ye J, Ling J. Comparative study of conventional diffusion-weighted imaging and introvoxel incoherent motion in assessment of pathological grade of clear cell renal cell carcinoma. Br J Radiol. 2022;95(1133):20210485. https:\/\/doi.org\/10.1259\/bjr.20210485.","journal-title":"Br J Radiol"},{"issue":"4","key":"2008_CR19","doi-asserted-by":"publisher","first-page":"e190094","DOI":"10.1148\/rycan.2020190094","volume":"2","author":"SJ Hectors","year":"2020","unstructured":"Hectors SJ, Lewis S, Kennedy P, Bane O, Said D, Segall M, et al. Assessment of hepatocellular carcinoma response to 90Y radioembolization using dynamic contrast material-enhanced MRI and intravoxel incoherent motion diffusion-weighted imaging. Radiol Imaging Cancer. 2020;2(4):e190094. https:\/\/doi.org\/10.1148\/rycan.2020190094.","journal-title":"Radiol Imaging Cancer"},{"key":"2008_CR20","doi-asserted-by":"publisher","first-page":"705964","DOI":"10.3389\/fonc.2021.705964","volume":"11","author":"ES Kooreman","year":"2021","unstructured":"Kooreman ES, van Houdt PJ, Keesman R, van Pelt VWJ, Nowee ME, Pos F, et al. Daily intravoxel incoherent motion (IVIM) in prostate cancer patients during MR-guided radiotherapy: a multicenter study. Front Oncol. 2021;11:705964. https:\/\/doi.org\/10.3389\/fonc.2021.705964.","journal-title":"Front Oncol"},{"issue":"12","key":"2008_CR21","doi-asserted-by":"publisher","first-page":"9182","DOI":"10.1007\/s00330-023-09813-8","volume":"33","author":"X Bao","year":"2023","unstructured":"Bao X, Bian D, Yang X, Wang Z, Shang M, Jiang G, Shi J. Multiparametric MRI for evaluation of pathological response to the neoadjuvant chemo-immunotherapy in resectable non-small-cell lung cancer. Eur Radiol. 2023;33(12):9182\u201393. https:\/\/doi.org\/10.1007\/s00330-023-09813-8.","journal-title":"Eur Radiol"},{"key":"2008_CR22","doi-asserted-by":"publisher","first-page":"102667","DOI":"10.1016\/j.ctrv.2023.102667","volume":"122","author":"H Bolek","year":"2024","unstructured":"Bolek H, Yeked\u00fcz E, \u00dcr\u00fcn Y. Combination therapies in patients with favorable risk metastatic renal cell carcinoma: a systematic review and meta-analysis. Cancer Treat Rev. 2024;122:102667. https:\/\/doi.org\/10.1016\/j.ctrv.2023.102667.","journal-title":"Cancer Treat Rev"},{"issue":"6","key":"2008_CR23","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.21037\/qims-19-985a","volume":"10","author":"M Fan","year":"2020","unstructured":"Fan M, Xing Z, Du Y, Pan L, Sun Y, He X. Quantitative assessment of renal allograft pathologic changes: comparisons of mono-exponential and bi-exponential models using diffusion-weighted imaging. Quant Imaging Med Surg. 2020;10(6):1286\u201397. https:\/\/doi.org\/10.21037\/qims-19-985a.","journal-title":"Quant Imaging Med Surg"},{"issue":"1","key":"2008_CR24","doi-asserted-by":"publisher","first-page":"100","DOI":"10.2214\/AJR.14.13923","volume":"206","author":"AM H\u00f6tker","year":"2016","unstructured":"H\u00f6tker AM, Mazaheri Y, Wibmer A, Zheng J, Moskowitz CS, Tickoo SK, et al. Use of DWI in the differentiation of renal cortical tumors. Am J Roentgenol. 2016;206(1):100\u20135. https:\/\/doi.org\/10.2214\/AJR.14.13923.","journal-title":"Am J Roentgenol"},{"issue":"1","key":"2008_CR25","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1002\/jmri.28763","volume":"59","author":"J Zhao","year":"2024","unstructured":"Zhao J, Wang M, Ding X, Fu Y, Peng C, Kang H, et al. Intravoxel incoherent motion diffusion-weighted mr imaging and venous tumor thrombus consistency in renal cell carcinoma. J Magn Reson Imaging. 2024;59(1):134\u201345. https:\/\/doi.org\/10.1002\/jmri.28763.","journal-title":"J Magn Reson Imaging"},{"issue":"3","key":"2008_CR26","doi-asserted-by":"publisher","first-page":"e143","DOI":"10.1016\/S1470-2045(17)30074-8","volume":"18","author":"L Seymour","year":"2017","unstructured":"Seymour L, Bogaerts J, Perrone A, Ford R, Schwartz LH, Mandrekar S, et al. iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics. Lancet Oncol. 2017;18(3):e143\u201352. https:\/\/doi.org\/10.1016\/S1470-2045(17)30074-8.","journal-title":"Lancet Oncol"},{"issue":"2","key":"2008_CR27","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228\u201347. https:\/\/doi.org\/10.1016\/j.ejca.2008.10.026.","journal-title":"Eur J Cancer"},{"issue":"5","key":"2008_CR28","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.eururo.2022.06.016","volume":"82","author":"H Moch","year":"2022","unstructured":"Moch H, Amin MB, Berney DM, Comp\u00e9rat EM, Gill AJ, Hartmann A, et al. The 2022 world health organization classification of tumours of the urinary system and male genital organs-part a: renal, penile, and testicular tumours. Eur Urol. 2022;82(5):458\u201368. https:\/\/doi.org\/10.1016\/j.eururo.2022.06.016.","journal-title":"Eur Urol"},{"issue":"10","key":"2008_CR29","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1038\/bjc.2014.518","volume":"111","author":"RR Singh","year":"2014","unstructured":"Singh RR, Patel KP, Routbort MJ, Aldape K, Lu X, Manekia J, et al. Clinical massively parallel next-generation sequencing analysis of 409 cancer-related genes for mutations and copy number variations in solid tumours. Br J Cancer. 2014;111(10):2014\u201323. https:\/\/doi.org\/10.1038\/bjc.2014.518.","journal-title":"Br J Cancer"},{"issue":"5","key":"2008_CR30","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453\u20137. https:\/\/doi.org\/10.1038\/nmeth.3337.","journal-title":"Nat Methods"},{"key":"2008_CR31","doi-asserted-by":"crossref","unstructured":"Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33 (1):159\u201374.","DOI":"10.2307\/2529310"},{"issue":"5","key":"2008_CR32","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1213\/ANE.0000000000002864","volume":"126","author":"P Schober","year":"2018","unstructured":"Schober P, Boer C, Schwarte LA. Correlation coefficients: appropriate use and interpretation. Anesth Analg. 2018;126(5):1763\u20138. https:\/\/doi.org\/10.1213\/ANE.0000000000002864.","journal-title":"Anesth Analg"},{"issue":"4","key":"2008_CR33","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1002\/mrm.24810","volume":"71","author":"H-J Lee","year":"2014","unstructured":"Lee H-J, Rha SY, Chung YE, Shim HS, Kim YJ, Hur J, et al. Tumor perfusion-related parameter of diffusion-weighted magnetic resonance imaging: correlation with histological microvessel density. Magn Reson Med. 2014;71(4):1554\u20138. https:\/\/doi.org\/10.1002\/mrm.24810.","journal-title":"Magn Reson Med"},{"issue":"1","key":"2008_CR34","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12967-024-04975-5","volume":"22","author":"X Xu","year":"2024","unstructured":"Xu X, Ma M, Ye K, Zhang D, Chen X, Wu J, et al. Magnetic resonance imaging-based approaches for detecting the efficacy of combining therapy following VEGFR-2 and PD-1 blockade in a colon cancer model. J Transl Med. 2024;22(1):198. https:\/\/doi.org\/10.1186\/s12967-024-04975-5.","journal-title":"J Transl Med"},{"issue":"7","key":"2008_CR35","doi-asserted-by":"publisher","first-page":"e176","DOI":"10.1016\/j.acra.2019.10.010","volume":"27","author":"J Ye","year":"2020","unstructured":"Ye J, Xu Q, Wang S-A, Zheng J, Dou W-Q. Quantitative evaluation of intravoxel incoherent motion and diffusion kurtosis imaging in assessment of pathological grade of clear cell renal cell carcinoma. Acad Radiol. 2020;27(7):e176\u201382. https:\/\/doi.org\/10.1016\/j.acra.2019.10.010.","journal-title":"Acad Radiol"},{"issue":"2","key":"2008_CR36","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1148\/radiol.2020201763","volume":"298","author":"LL Tsai","year":"2021","unstructured":"Tsai LL, Bhatt RS, Strob MF, Jegede OA, Sun MRM, Alsop DC, et al. Arterial spin labeled perfusion MRI for the evaluation of response to tyrosine kinase inhibition therapy in metastatic renal cell carcinoma. Radiology. 2021;298(2):332\u201340. https:\/\/doi.org\/10.1148\/radiol.2020201763.","journal-title":"Radiology"},{"issue":"4","key":"2008_CR37","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1002\/imt2.147","volume":"2","author":"J Meng","year":"2023","unstructured":"Meng J, Jiang A, Lu X, Di Gu, Ge Q, Bai S, et al. Multiomics characterization and verification of clear cell renal cell carcinoma molecular subtypes to guide precise chemotherapy and immunotherapy. Imeta. 2023;2(4):e147. https:\/\/doi.org\/10.1002\/imt2.147.","journal-title":"Imeta"},{"issue":"385","key":"2008_CR38","doi-asserted-by":"publisher","first-page":"eaak9679","DOI":"10.1126\/scitranslmed.aak9679","volume":"9","author":"E Allen","year":"2017","unstructured":"Allen E, Jabouille A, Rivera LB, et al. Combined antiangiogenic and anti-PD-L1 therapy stimulates tumor immunity through HEV formation. Sci Transl Med. 2017;9(385):eaak9679. https:\/\/doi.org\/10.1126\/scitranslmed.aak9679.","journal-title":"Sci Transl Med"},{"issue":"1","key":"2008_CR39","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1148\/radiol.2015150244","volume":"278","author":"M Iima","year":"2016","unstructured":"Iima M, Le Bihan D. Clinical intravoxel incoherent motion and diffusion mr imaging: past, present, and future. Radiology. 2016;278(1):13\u201332. https:\/\/doi.org\/10.1148\/radiol.2015150244.","journal-title":"Radiology"},{"issue":"9","key":"2008_CR40","doi-asserted-by":"publisher","first-page":"e004708","DOI":"10.1136\/jitc-2022-004708","volume":"10","author":"D Lau","year":"2022","unstructured":"Lau D, Corrie PG, Gallagher FA. MRI techniques for immunotherapy monitoring. J Immunother Cancer. 2022;10(9):e004708. https:\/\/doi.org\/10.1136\/jitc-2022-004708.","journal-title":"J Immunother Cancer"},{"issue":"6","key":"2008_CR41","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.eururo.2022.01.043","volume":"81","author":"MI Carlo","year":"2022","unstructured":"Carlo MI, Attalla K, Mazaheri Y, Gupta S, Yildirim O, Murray SJ, et al. Phase II study of neoadjuvant nivolumab in patients with locally advanced clear cell renal cell carcinoma undergoing nephrectomy. Eur Urol. 2022;81(6):570\u20133. https:\/\/doi.org\/10.1016\/j.eururo.2022.01.043.","journal-title":"Eur Urol"},{"issue":"12","key":"2008_CR42","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/s41577-021-00541-y","volume":"21","author":"K DePeaux","year":"2021","unstructured":"DePeaux K, Delgoffe GM. Metabolic barriers to cancer immunotherapy. Nat Rev Immunol. 2021;21(12):785\u201397. https:\/\/doi.org\/10.1038\/s41577-021-00541-y.","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"2008_CR43","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.tcb.2020.06.003","volume":"30","author":"M St Paul","year":"2020","unstructured":"St Paul M, Ohashi PS. The roles of CD8\u2009+\u2009T cell subsets in antitumor immunity. Trends Cell Biol. 2020;30(9):695\u2013704. https:\/\/doi.org\/10.1016\/j.tcb.2020.06.003.","journal-title":"Trends Cell Biol"},{"issue":"3","key":"2008_CR44","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.cell.2021.01.002","volume":"184","author":"K Litchfield","year":"2021","unstructured":"Litchfield K, Reading JL, Puttick C, Thakkar K, Abbosh C, Bentham R, et al. Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition. Cell. 2021;184(3):596\u2013e61414. https:\/\/doi.org\/10.1016\/j.cell.2021.01.002.","journal-title":"Cell"},{"key":"2008_CR45","doi-asserted-by":"publisher","first-page":"745945","DOI":"10.3389\/fimmu.2021.745945","volume":"12","author":"X Wu","year":"2021","unstructured":"Wu X, Jiang D, Liu H, Lu X, Lv D, Liang L. CD8\u2009+\u2009T cell-based molecular classification with heterogeneous immunogenomic landscapes and clinical significance of clear cell renal cell carcinoma. Front Immunol. 2021;12:745945. https:\/\/doi.org\/10.3389\/fimmu.2021.745945.","journal-title":"Front Immunol"},{"issue":"17","key":"2008_CR46","doi-asserted-by":"publisher","first-page":"9659","DOI":"10.3390\/ijms25179659","volume":"25","author":"LA Pavelescu","year":"2024","unstructured":"Pavelescu LA, Enache RM, Ro\u015fu OA, Profir M, Cre\u0163oiu SM, Gaspar BS. Predictive biomarkers and resistance mechanisms of checkpoint inhibitors in malignant solid tumors. Int J Mol Sci. 2024;25(17):9659. https:\/\/doi.org\/10.3390\/ijms25179659.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2008_CR47","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1002\/jmri.24799","volume":"42","author":"S Suo","year":"2015","unstructured":"Suo S, Lin N, Wang H, Zhang L, Wang R, Zhang S, et al. Intravoxel incoherent motion diffusion-weighted MR imaging of breast cancer at 3.0 tesla: comparison of different curve-fitting methods. J Magn Reson Imaging. 2015;42(2):362\u201370. https:\/\/doi.org\/10.1002\/jmri.24799.","journal-title":"J Magn Reson Imaging"}],"container-title":["Japanese Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11604-026-02008-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11604-026-02008-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11604-026-02008-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T05:17:31Z","timestamp":1787980651000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11604-026-02008-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":47,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["2008"],"URL":"https:\/\/doi.org\/10.1007\/s11604-026-02008-3","relation":{},"ISSN":["1867-1071","1867-108X"],"issn-type":[{"value":"1867-1071","type":"print"},{"value":"1867-108X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,21]]},"assertion":[{"value":"25 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}